JAZZ PHARMACEUTICALS
Updated 9 days ago
XYREM is a Central Nervous System (CNS) depressant. In clinical trials at recommended doses, obtundation and clinically significant respiratory depression occurred in adult patients treated with XYREM. Many patients who received XYREM during clinical trials in narcolepsy were receiving CNS stimulants...
XYREM is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death.
Also known as: Jazz Pharmaceuticals plc
Associated domains: narcolepsydx.info, treating-narcolepsy-hcp.com, xyremadvisors.com, xyremnarcolepsy.info, xyremnarcolepsy.org, xyremtrials.info, zyrem.org, zyrum.com